Market Place
Sourcing Support
FDA Issues Form 483 to Zhejiang Hisun Pharmaceuticals [8.11.17 483]
30 Mar 2022 //
FDA
FDA Issues Form 483 to Zhejiang Hisun Pharmaceuticals
30 Mar 2022 //
FDA
Zhejiang Hisun Pharmaceutical Free of COVID-19, Gov Suggest Favipiravir
30 Jun 2020 //
PRNEWSWIRE
Zhejiang Hisun Pharma Free of COVID-19, Governments Suggest Favipiravir
26 Jun 2020 //
PRNEWSWIRE
Zhejiang Hisun Pharma Free of COVID-19, Governments Suggest Favipiravir
26 Jun 2020 //
PRNEWSWIRE
Zhejiang Hisun Pharma Les gouvernements recommandent le Favipiravir
26 Jun 2020 //
BUSINESSWIRE
Zhejiang Hisun Pharmaceutical Co.Free of COVID-19, Governments Favipiravir
26 Jun 2020 //
BUSINESSWIRE
Zhejiang Hisun Pharmaceutical on Health Canada Inspection list
25 Jun 2020 //
HEALTH CANADA
Zhejiang Hisun shows positive effect of Favipiravir on COVID-19
20 Mar 2020 //
BIOSPECTRUMASIA
Zhejiang Hisun Pharma Favipiravir Works - Preliminary Clinical Studies COVID-19
19 Mar 2020 //
PRNEWSWIRE
Zhejiang Hisun Pharma gets approval for trial to test flu drug Favipiravir
17 Mar 2020 //
REUTERS
Favilavir approved as experimental coronavirus drug
22 Feb 2020 //
PHARMACEUTICAL TECHNOLOGY
China approves first anti-viral drug against coronavirus Covid-19
18 Feb 2020 //
CLINICALTRIALSARENA
PAG infuses $540M to gain control of Hisun`s biosimilar subsidiary
06 Sep 2019 //
ENDPTS
Zhejiang Hisun Pharmaceutical Co., Ltd. (Yantou Campus) Fail EDQM Campus
30 Jul 2019 //
EDQM
Zhejiang Hisun Pharmaceutical Co., Ltd – East Campus Fails EDQM Inspection
30 Jul 2019 //
EDQM
Zhejiang Hisun Pharm’s Generic Mycophenolate Mofetil Receives Approval In US
16 Nov 2017 //
FDA
Pfizer exits China joint venture for generic drugs
10 Nov 2017 //
REUTERS
28 Unique Data Integrity Deficiencies That Aren’t Really Unique
02 Jun 2017 //
FDAZILLA
Zhejiang Hisun Pharmaceutical Co. Ltd. On Health Canada Inspection List
11 Jan 2017 //
HEALTH CANADA
Zhejiang Hisun Pharmaceutical, Co (East Factory Campus) Fails EDQM Inspection
19 Sep 2016 //
EDQM
Zhejiang Hisun Pharmaceutical, Co., Ltd. (Waisha Campus) Fails EDQM Inspection
19 Sep 2016 //
EDQM
Zhejiang Hisun Pharmaceutical, Co., Ltd. (Yantou Campus) Fails EDQM Inspection
19 Sep 2016 //
EDQM
Zhejiang Hisun Pharmaceutical Co., Ltd on USFDA Import Alert
18 Feb 2016 //
FDA
Zhejiang Hisun Pharmaceutical receives warning letter due to cGMP deviations
31 Dec 2015 //
FDA
Zhejiang Hisun on FDA Import Alert List
10 Sep 2015 //
Health Canada requests quarantine of drugs linked to Zhejiang Hisun Pharma due to data integrity concerns
18 Jun 2015 //
HEALTHY CANADIANS
Zhejiang Hisun Pharma drugs quarantined due to data integrity concerns
17 Jun 2015 //
HEALTHY CANADIANS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.